BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 37794349)

  • 1. Bcl-3 regulates T cell function through energy metabolism.
    Liu H; Zeng L; Pan M; Huang L; Li H; Liu M; Niu X; Zhang C; Wang H
    BMC Immunol; 2023 Oct; 24(1):35. PubMed ID: 37794349
    [TBL] [Abstract][Full Text] [Related]  

  • 2. BCL-3 expression promotes colorectal tumorigenesis through activation of AKT signalling.
    Urban BC; Collard TJ; Eagle CJ; Southern SL; Greenhough A; Hamdollah-Zadeh M; Ghosh A; Poulsom R; Paraskeva C; Silver A; Williams AC
    Gut; 2016 Jul; 65(7):1151-64. PubMed ID: 26033966
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The NF-kappa B cascade is important in Bcl-xL expression and for the anti-apoptotic effects of the CD28 receptor in primary human CD4+ lymphocytes.
    Khoshnan A; Tindell C; Laux I; Bae D; Bennett B; Nel AE
    J Immunol; 2000 Aug; 165(4):1743-54. PubMed ID: 10925251
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Eriocalyxin B induces apoptosis in lymphoma cells through multiple cellular signaling pathways.
    Zhang YW; Jiang XX; Chen QS; Shi WY; Wang L; Sun HD; Shen ZX; Chen Z; Chen SJ; Zhao WL
    Exp Hematol; 2010 Mar; 38(3):191-201. PubMed ID: 20045442
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-proliferative effect of RCE-4 from Reineckia carnea on human cervical cancer HeLa cells by inhibiting the PI3K/Akt/mTOR signaling pathway and NF-κB activation.
    Bai C; Yang X; Zou K; He H; Wang J; Qin H; Yu X; Liu C; Zheng J; Cheng F; Chen J
    Naunyn Schmiedebergs Arch Pharmacol; 2016 Jun; 389(6):573-84. PubMed ID: 26935715
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protein kinase C-theta-mediated signals enhance CD4+ T cell survival by up-regulating Bcl-xL.
    Manicassamy S; Gupta S; Huang Z; Sun Z
    J Immunol; 2006 Jun; 176(11):6709-16. PubMed ID: 16709830
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Akt-dependent glucose metabolism promotes Mcl-1 synthesis to maintain cell survival and resistance to Bcl-2 inhibition.
    Coloff JL; Macintyre AN; Nichols AG; Liu T; Gallo CA; Plas DR; Rathmell JC
    Cancer Res; 2011 Aug; 71(15):5204-13. PubMed ID: 21670080
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FADD and the NF-kappaB family member Bcl-3 regulate complementary pathways to control T-cell survival and proliferation.
    Rangelova S; Kirschnek S; Strasser A; Häcker G
    Immunology; 2008 Dec; 125(4):549-57. PubMed ID: 18557791
    [TBL] [Abstract][Full Text] [Related]  

  • 9. mTOR, metabolism, and the regulation of T-cell differentiation and function.
    Waickman AT; Powell JD
    Immunol Rev; 2012 Sep; 249(1):43-58. PubMed ID: 22889214
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The inhibition of cell proliferation and induction of apoptosis in pancreatic ductal adenocarcinoma cells by verrucarin A, a macrocyclic trichothecene, is associated with the inhibition of Akt/NF-кB/mTOR prosurvival signaling.
    Deeb D; Gao X; Liu Y; Zhang Y; Shaw J; Valeriote FA; Gautam SC
    Int J Oncol; 2016 Sep; 49(3):1139-47. PubMed ID: 27573873
    [TBL] [Abstract][Full Text] [Related]  

  • 11. miR-155 Controls Lymphoproliferation in LAT Mutant Mice by Restraining T-Cell Apoptosis via SHIP-1/mTOR and PAK1/FOXO3/BIM Pathways.
    Rouquette-Jazdanian AK; Kortum RL; Li W; Merrill RK; Nguyen PH; Samelson LE; Sommers CL
    PLoS One; 2015; 10(6):e0131823. PubMed ID: 26121028
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Involvement of NF-κB in mediating the anti-tumour effects of combretastatins in T cells.
    Pollock JK; Greene LM; Nathwani SM; Kinsella P; O'Boyle NM; Meegan MJ; Zisterer DM
    Invest New Drugs; 2018 Aug; 36(4):523-535. PubMed ID: 29460212
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular mechanisms of metabolic reprogramming in proliferating cells: implications for T-cell-mediated immunity.
    Marelli-Berg FM; Fu H; Mauro C
    Immunology; 2012 Aug; 136(4):363-9. PubMed ID: 22384794
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tormentic acid inhibits hepatic stellate cells activation via blocking PI3K/Akt/mTOR and NF-κB signalling pathways.
    Lin X; Li Y; Zhang X; Wei Y; Wen S; Lu Z; Huang Q; Wei J
    Cell Biochem Funct; 2021 Jan; 39(1):77-87. PubMed ID: 32564421
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tetrandrine and cepharanthine induce apoptosis through caspase cascade regulation, cell cycle arrest, MAPK activation and PI3K/Akt/mTOR signal modification in glucocorticoid resistant human leukemia Jurkat T cells.
    Xu W; Wang X; Tu Y; Masaki H; Tanaka S; Onda K; Sugiyama K; Yamada H; Hirano T
    Chem Biol Interact; 2019 Sep; 310():108726. PubMed ID: 31255635
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protein kinase B regulates T lymphocyte survival, nuclear factor kappaB activation, and Bcl-X(L) levels in vivo.
    Jones RG; Parsons M; Bonnard M; Chan VS; Yeh WC; Woodgett JR; Ohashi PS
    J Exp Med; 2000 May; 191(10):1721-34. PubMed ID: 10811865
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TNFAIP3 promotes survival of CD4 T cells by restricting MTOR and promoting autophagy.
    Matsuzawa Y; Oshima S; Takahara M; Maeyashiki C; Nemoto Y; Kobayashi M; Nibe Y; Nozaki K; Nagaishi T; Okamoto R; Tsuchiya K; Nakamura T; Ma A; Watanabe M
    Autophagy; 2015; 11(7):1052-62. PubMed ID: 26043155
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fisetin inhibits laryngeal carcinoma through regulation of AKT/NF-κB/mTOR and ERK1/2 signaling pathways.
    Zhang XJ; Jia SS
    Biomed Pharmacother; 2016 Oct; 83():1164-1174. PubMed ID: 27551764
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Conditional Disruption of Raptor Reveals an Essential Role for mTORC1 in B Cell Development, Survival, and Metabolism.
    Iwata TN; Ramírez JA; Tsang M; Park H; Margineantu DH; Hockenbery DM; Iritani BM
    J Immunol; 2016 Sep; 197(6):2250-60. PubMed ID: 27521345
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ginsenoside Rh2 impedes proliferation and migration and induces apoptosis by regulating NF-κB, MAPK, and PI3K/Akt/mTOR signaling pathways in osteosarcoma cells.
    Li C; Gao H; Feng X; Bi C; Zhang J; Yin J
    J Biochem Mol Toxicol; 2020 Dec; 34(12):e22597. PubMed ID: 32762018
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.